| 1 |
Dristant U, Mukherjee K, Saha S, Maity D. An Overview of Polymeric Nanoparticles-Based Drug Delivery System in Cancer Treatment. Technol Cancer Res Treat 2023;22:15330338231152083. [PMID: 36718541 DOI: 10.1177/15330338231152083] [Reference Citation Analysis]
|
| 2 |
Fernandes DA. Review on the applications of nanoemulsions in cancer theranostics. Journal of Materials Research. [DOI: 10.1557/s43578-022-00583-5] [Reference Citation Analysis]
|
| 3 |
Azizi M, Kokabi H, Dianat-moghadam H, Mehrmohammadi M. Tumor-specific imaging probes in preclinical applications and clinical trials. Targeted Cancer Imaging 2022. [DOI: 10.1016/b978-0-12-824513-2.00004-8] [Reference Citation Analysis]
|
| 4 |
Shakeri-zadeh A, Rezaeyan A, Sarikhani A, Ghaffari H, Samadian H, Khademi S, Ghaznavi H, Bulte JW. Folate receptor-targeted nanoprobes for molecular imaging of cancer: Friend or foe? Nano Today 2021;39:101173. [DOI: 10.1016/j.nantod.2021.101173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 5 |
Parakasikron N, Chaotham C, Chanvorachote P, Vinayanuwattikun C, Buranasudja V, Taweecheep P, Khantasup K. Development of a human antibody fragment directed against the alpha folate receptor as a promising molecule for targeted application. Drug Deliv 2021;28:1443-54. [PMID: 34236266 DOI: 10.1080/10717544.2021.1943055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Kandasamy G, Maity D. Multifunctional theranostic nanoparticles for biomedical cancer treatments - A comprehensive review. Mater Sci Eng C Mater Biol Appl 2021;127:112199. [PMID: 34225852 DOI: 10.1016/j.msec.2021.112199] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
|
| 7 |
Lima PHC, Butera AP, Cabeça LF, Ribeiro-Viana RM. Liposome surface modification by phospholipid chemical reactions. Chem Phys Lipids 2021;237:105084. [PMID: 33891960 DOI: 10.1016/j.chemphyslip.2021.105084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 8 |
Al-Thiabat MG, Saqallah FG, Gazzali AM, Mohtar N, Yap BK, Choong YS, Wahab HA. Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight. Molecules 2021;26:1079. [PMID: 33670773 DOI: 10.3390/molecules26041079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 9 |
Wu R, Liang C, Zou J, Li C, Yan Y, Hu X, Ling X. Detection of membrane receptors on per tumor cell by nonimmobilized cell capillary electrophoresis and a mathematic model. Talanta 2021;222:121425. [PMID: 33167195 DOI: 10.1016/j.talanta.2020.121425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Azizi M, Dianat-Moghadam H, Salehi R, Farshbaf M, Iyengar D, Sau S, Iyer AK, Valizadeh H, Mehrmohammadi M, Hamblin MR. Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications. Adv Funct Mater 2020;30:1910402. [PMID: 34093104 DOI: 10.1002/adfm.201910402] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 11 |
Gorain B, Choudhury H, Nair AB, Dubey SK, Kesharwani P. Theranostic application of nanoemulsions in chemotherapy. Drug Discov Today 2020;25:1174-88. [PMID: 32344042 DOI: 10.1016/j.drudis.2020.04.013] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 12 |
Saito A, Yamamoto S, Ochi R, Inoue K, Hadano S, Watanabe S, Nakayama T, Niko Y. An Azide-Tethered Cremophor ® ELP Surfactant Allowing Facile Post-Surface Functionalization of Nanoemulsions. BCSJ 2020;93:568-75. [DOI: 10.1246/bcsj.20200014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 13 |
Farran B, Montenegro RC, Kasa P, Pavitra E, Huh YS, Han YK, Kamal MA, Nagaraju GP, Rama Raju GS. Folate-conjugated nanovehicles: Strategies for cancer therapy. Mater Sci Eng C Mater Biol Appl 2020;107:110341. [PMID: 31761235 DOI: 10.1016/j.msec.2019.110341] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 14 |
Hou W, Lou JWH, Bu J, Chang E, Ding L, Valic M, Jeon HH, Charron DM, Coolens C, Cui D, Chen J, Zheng G. A Nanoemulsion with A Porphyrin Shell for Cancer Theranostics. Angew Chem Int Ed Engl 2019;58:14974-8. [PMID: 31410962 DOI: 10.1002/anie.201908664] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 15 |
Hou W, Lou JWH, Bu J, Chang E, Ding L, Valic M, Jeon HH, Charron DM, Coolens C, Cui D, Chen J, Zheng G. A Nanoemulsion with A Porphyrin Shell for Cancer Theranostics. Angew Chem 2019;131:15116-20. [DOI: 10.1002/ange.201908664] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 16 |
Choudhury H, Pandey M, Yin TH, Kaur T, Jia GW, Tan SQL, Weijie H, Yang EKS, Keat CG, Bhattamishra SK, Kesharwani P, Md S, Molugulu N, Pichika MR, Gorain B. Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology. Mater Sci Eng C Mater Biol Appl 2019;101:596-613. [PMID: 31029353 DOI: 10.1016/j.msec.2019.04.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 17 |
Cheng F, Sun P, Xiong W, Zhang Y, Zhang Q, Yao W, Cao Y, Zhang L. Multifunctional titanium phosphate nanoparticles for site-specific drug delivery and real-time therapeutic efficacy evaluation. Analyst 2019;144:3103-10. [DOI: 10.1039/c8an02450b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 18 |
Sun Y, Shi T, Zhou Y, Zhou L, Sun B. Folate-decorated and NIR-triggered nanoparticles loaded with platinum(IV)-prodrug plus 5-fluorouracil for targeted and chemo-photothermal combination therapy. Journal of Drug Delivery Science and Technology 2018;48:40-8. [DOI: 10.1016/j.jddst.2018.08.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 19 |
Patel NR, Piroyan A, Ganta S, Morse AB, Candiloro KM, Solon AL, Nack AH, Galati CA, Bora C, Maglaty MA, O'Brien SW, Litwin S, Davis B, Connolly DC, Coleman TP. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers. Cancer Biol Ther 2018;19:554-64. [PMID: 29737910 DOI: 10.1080/15384047.2017.1395118] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 20 |
Kevadiya BD, Woldstad C, Ottemann BM, Dash P, Sajja BR, Lamberty B, Morsey B, Kocher T, Dutta R, Bade AN, Liu Y, Callen SE, Fox HS, Byrareddy SN, McMillan JM, Bronich TK, Edagwa BJ, Boska MD, Gendelman HE. Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics 2018;8:256-76. [PMID: 29290806 DOI: 10.7150/thno.22764] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 21 |
Fernández M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem Sci 2018;9:790-810. [PMID: 29675145 DOI: 10.1039/c7sc04004k] [Cited by in Crossref: 262] [Cited by in F6Publishing: 273] [Article Influence: 43.7] [Reference Citation Analysis]
|
| 22 |
Sun Y, Shi T, Zhou L, Zhou Y, Sun B, Liu X. Folate-decorated and NIR-activated nanoparticles based on platinum(IV) prodrugs for targeted therapy of ovarian cancer. Journal of Microencapsulation 2017;34:675-86. [DOI: 10.1080/02652048.2017.1393114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 23 |
Guissi NEI, Li H, Xu Y, Semcheddine F, Chen M, Su Z, Ping Q. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy. Mol Pharmaceutics 2017;14:1082-94. [DOI: 10.1021/acs.molpharmaceut.6b01009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
